Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Metabolic diseases, such as cardiovascular diseases and type 2 diabetes, have become one of the world’s largest public health ...

On the other hand, semaglutide’s close competitor tirzepatide—a drug by US pharma firm Eli Lilly and Company which is ...

New therapies for atherosclerosis, obesity and type 2 diabetes are needed. Thyroid hormone excess has potentially useful effects, including lowering of serum cholesterol and reduction of body fat ...

Novo Nordisk's experimental obesity drug CagriSema shows similar side effects to its GLP-1 drugs, with potential for 25% ...

It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

AstraZeneca said on Monday its experimental weight-loss pill, licensed a year ago from China's Eccogene for up to $2 billion, ...

While the explanation for this disparity is far from definitive, hormones are believed ... are modifiable include smoking, obesity, exposure to environmental toxins, mental health conditions, ...

In recent years, researchers have been accumulating evidence to suggest that certain beers could help improve the diversity of species in the gut microbiome, something which tends to be associated ...

“Among people with overweight or obesity, one in three live with MASH ... These medications act on gut hormones and are proven to have powerful effects on weight loss, heart health and other ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...